Bandingkan Harga & Kinerja ABM Investama Tbk (ABMM) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan ABM Investama Tbk dan Brigit Biofarmaka Teknologi Tbk.: ABM Investama Tbk diperdagangkan di Rp2.650 (kapitalisasi pasar 7,35 T, volume 24 jam 122,7 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: ABM Investama Tbk jauh lebih besar — sekitar 44,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (187,4 rb vs 122,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ABMM | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 7,35 T | 164,65 M |
Volume | 122,7 rb | 187,4 rb |
Lot | 1,23 rb | 1,87 rb |
Perputaran | 324,84 jt | 44,35 jt |
Harga Rata-rata | 2.647,42 | 236,67 |
Nilai Transaksi | 324,84 jt | 44,35 jt |
Harga Ekuilibrium Indikatif | 2.680 | 242 |
Volume Ekuilibrium Indikatif | 14 | 500 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang ABM Investama Tbk
ABM Investama, PT (the company) was established under its original name of PT Adiratna Bani Makmur on Jun 1, 2006 then changed to PT ABM Investama Tbk based on Notaries Deed dated Aug 31, 2009. The deed of establishment was approved by the the Ministry of Justice dated Oct 16, 2009. The Company’s articles of association has been amended several times, most recently by notarial deed No. 163 of Mrs. Aulia Taufani, S.H., dated Jul 21, 2011, concerning among others, public offering of stock.
Selengkapnya di halaman ABMM →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
